Rallis India Limited (A TATA Enterprise) is a leading player in the Indian agri inputs industry announced its financial results for the quarter and half year ended September 30, 2025
Key Highlights: Q2 & H1 FY26
Announcing the results, Dr Gyanendra Shukla, Managing Director & CEO, Rallis India Limited, said,
Despite challenging weather conditions, the company delivered steady profitability and strong cash generation, supported by cost optimization, disciplined operations and robust export growth.
During the quarter, the company recorded revenue of ₹861 crore, compared to ₹928 crore in Q2 FY25, reflecting a 7% decline mainly due to erratic and prolonged rains in several parts of the country that impacted field activities and spray applications. PAT grew by 4% to ₹102 crore, compared to ₹98 crore in the corresponding quarter last year. The company's PAT margin improved by 120 basis points to 11.8%. EBITDA for the quarter stood at ₹154 crore as against ₹166 crore in Q2 FY25. Strong cash management continued with Free Cash Flow of ₹52 crore, zero external debt, and a healthy closing cash and liquid balance of ₹454 crore.
For the half year ended September 2025, Rallis reported revenue of ₹1,818 crore, a 6% increase over ₹1,711 crore in H1 FY25. EBITDA grew by 16% to ₹303 crore compared to ₹261 crore last year, while PAT grew 35% to ₹197 crore against ₹146 crore in H1 FY25. The company achieved a PAT margin of 10.8%, up from 8.5% in the previous year, reflecting improved operational efficiency and a richer product mix.
Business Performance: Q2 FY26
In Q2, the Crop Care B2B business grew by 14% YoY on the back of volume revival in key molecules and better capacity utilization, while Crop Protection B2C business performance declined 10% YoY due to weather disruptions and erratic rainfall across major markets. Soil & Plant Health (SPH) business declined by 20%, due to regulatory challenges in the Biostimulants category.
However, exports registered a growth of 33% driven by higher volume in key molecules.
The Seeds business recorded revenue of ₹101 crore compared to ₹141 crore in Q2 FY25, primarily due to supply chain constraints, though higher gross margins and effective pricing helped mitigate the impact.
Rallis continued to expand its portfolio with eight new product launches during H1 FY26, including Penflor, Allato, Deeweed, Dodrio, Master Gold, Torris, Vaar and Teer, strengthening its position across herbicides and fungicides. The company also resumed biostimulant sales through in-house production, enhancing its footprint in sustainable crop solutions.
Management Comment
Commenting on the results, Dr. Gyanendra Shukla, Managing Director & CEO, Rallis India Limited, said:
Q2 was challenging due to prolonged rains which impacted field activities and product placement. Despite these headwinds, our profitability remained stable, supported by export momentum, prudent cost management, and improved margins in the Seeds business.
Our strong balance sheet, zero external debt and healthy cash position underscore our financial discipline and operational resilience.
.jpg)